Key Takeaways on AOD 9604 Investigational status: AOD 9604 is not an FDA-approved medication for fat loss or any other indication, which is why medical supervision is essential
Embrace a healthier, slimmer you with this transformative treatment
It encourages the breakdown of triglycerides in adipose tissue into fatty acids and glycerol, which be utilized as fuel
Primary concerns include increased injection site reactions from multiple subcutaneous injections, difficulty attributing adverse effects to the correct agent, additional cost without proven benefit, and potential quality variability in compounded lipotropic products
Others being discussed during the two-day meeting include TB-500 (touted for wound healing) and epitalon (ostensibly a hack for insomnia)
Laboratories remain responsible for internal validation, controlled handling, recordkeeping, and compliance procedures associated with the material after receipt